FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

The Harvard Drug Group NIFEdipine EXTENDED-RELEASE TABLETS Recall

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit do…

The Harvard Drug Group · Livonia, MI

Risk level
Class II
Reported by FDA
Jul 21, 2021
Recall ID
D-0652-2021
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled NIFEdipine EXTENDED-RELEASE TABLETS starting Jul 2, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0652-2021 on Jul 21, 2021. Reason: Failed Dissolution Specification: Out of specification for dissolution during routine stability testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

Product description

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

Lot numbers, UPCs & expiration codes

Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022

Where it was sold

Distributed in OH and NJ

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0652-2021
Classification
Class II
Status
Terminated
Recall initiated
Jul 2, 2021
FDA report date
Jul 21, 2021
Quantity
504 Cartons of 50 count each; 372 Cartons of 100 count each
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group

Original FDA data

Every field from FDA enforcement report D-0652-2021, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
88224
Address
17187 N Laurel Park Dr Ste 300
Code information
Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022
Postal code
48152-2600
Report date
Jul 21, 2021
Product type
Drugs
Recall number
D-0652-2021
Classification
Class II
Recalling firm
The Harvard Drug Group
Product quantity
504 Cartons of 50 count each; 372 Cartons of 100 count each
Termination date
Dec 28, 2022
Reason for recall
Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA
Distribution pattern
Distributed in OH and NJ
Recall initiation date
Jul 2, 2021
Initial firm notification
Letter
Center classification date
Jul 9, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0652-2021, published Jul 21, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls